• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Mérieux Equity Partners S.A.S.

Mérieux Equity Partners is a management company registered with the Autorité des Marchés Financiers (AMF) since June 2018, dedicated to growth equity and venture capital within the healthcare and nutrition sectors. Mérieux Equity Partners currently operates with an international team of 20 employees and regional partners – based in Europe and North America. Mérieux Equity Partners actively supports entrepreneurs and industrial companies whose products and services bring differentiated and innovative solutions, by providing privileged access to its expertise and the industrial, scientific and commercial network of Institut Mérieux, in compliance with current regulation. *

 

	Start	2018-06-01 established?
	Group	Mérieux (Group)
	Industry	private equity
	Industry 2	LIFE SCIENCES
	Region	Lyon
	Country	France
	City	n. a. Lyon
		Address record changed: 2020-12-02
Basic data	Employees	B: 11 to 50 (2020-01-08)
		* Document for �About Section�: Mérieux Equity Partners S.A.S.. (1/8/20). "Press Release: Mérieux Equity Partners Successfully Completes the Fundraising of Mérieux Participations 3". Lyon.
		Record changed: 2020-12-09

Advertisement

More documents for Mérieux (Group)

• [1] Mérieux Equity Partners S.A.S.. (12/8/20). "Press Release: Cell-Easy Announces the Completion of a Financing Round to Accelerate Its Growth Trajectory in the Cell Therapy Sector, With Merieux Equity Partners as Lead Investor and Reference Shareholder". T...
• [2] Transgene S.A.. (12/3/20). "Press Release: Transgene Appoints Hedi Ben Brahim as Chairman and Chief Executive Officer". Strasbourg....
• [3] Transgene S.A.. (5/4/20). "Press Release: Vaxxel Acquires Transgene’s DuckCelt-T17 Cell Line to Develop Industrial-scale Vaccines against Respiratory Viruses". Lyon & Strasbourg....
• [4] GeNeuro S.A.. (1/31/20). "Press Release: GeNeuro Announces Successful €17.5 Million Private Placement [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction where Unlawful]". Geneva....
• [5] Mérieux Equity Partners S.A.S.. (1/8/20). "Press Release: Mérieux Equity Partners Successfully Completes the Fundraising of Mérieux Participations 3". Lyon....
• [6] Keranova S.A.. (9/10/19). "Press Release: Keranova Raises €24m in Second Round of Financing". Saint-Etienne & Lyon....
• [7] Transgene S.A.. (7/2/19). "Press Release: Success of Transgene’s €48.7 Million Rights Issue [This document must not be distributed, directly or indirectly, in the United States of America, Australia, Canada or Japan]". Strasbourg....
• [8] Transgene S.A.. (6/14/19). "Press Release: Transgene Launches a Rights Issue for an Amount of up to €50 Million [This document must not be distributed, directly or indirectly, in the United States of America, Australia, Canada or Japan]". Strasbourg....
• [9] bioMérieux S.A.. (6/6/19). "Press Release: bioMérieux Increases Its Holding in Hybiome from 54% to 67%". Marcy l’Étoile....
• [10] Transgene S.A.. (5/2/19). "Press Release: Transgene and AstraZeneca Enter into a Collaboration and Exclusive License Option Agreement for Innovative Invir.IO based Armed Oncolytic Immunotherapies". Strasbourg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.